CoChat

A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression

The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.

Abstract

Twenty-five percent inhaled nitrous oxide improves symptoms of treatment-resistant major depression with fewer adverse effects than the 50% concentration.

Overview

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.abe1376

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 28 references

Cited by

See all 133

Metadata

Authors
Nagele, P., Palanca, B. J., Gott, B., Brown, F., Barnes, L., Nguyen, T., Xiong, W., Salloum, N. C., Espejo, G. D., Lessov-Schlaggar, C. N., Jain, N., Cheng, W. W. L., Komen, H., Yee, B., Bolzenius, J. D., Janski, A., Gibbons, R., Zorumski, C. F., & Conway, C. R.
Affiliations
  • Department of Anesthesia and Critical Care, University of Chicago, Chicago, IL 60637, USA.
  • Washington University in St. Louis (US)
  • University of Chicago (US)
  • Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA.
Venue
Science Translational Medicine
Published
2021-06-09
Volume
13
Issue
597
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
OpenAlex
W3170628472
Cited by
133
References
29
Citations by year
2026: 10 · 2025: 25 · 2024: 26 · 2023: 52 · 2022: 15 · 2021: 5
FWCI
14.31
Type
journal article
Language
en
Open access
closed
Locations
  • Science Translational Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
Brain and Behavior Research Foundation (24593)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
Keywords
major depressive disorder, treatment-resistant depression, adverse effects, depression treatment
MeSH terms
Antidepressive Agents, Depression, Major Depressive Disorder, Double-Blind Method, Humans, Nitrous Oxide, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression. https://app.cochat.ai/papers/10.1126/scitranslmed.abe1376
The paper
Nagele, P., Palanca, B. J., Gott, B., Brown, F., Barnes, L., Nguyen, T., Xiong, W., Salloum, N. C., Espejo, G. D., Lessov-Schlaggar, C. N., Jain, N., Cheng, W. W. L., Komen, H., Yee, B., Bolzenius, J. D., Janski, A., Gibbons, R., Zorumski, C. F., & Conway, C. R. (2021). A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.abe1376

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.